Kohlberg Kravis Roberts

Pfizer Sells Capsugel: Will More Asset Sales Follow?

On Monday, Pfizer announced it would sell its Capsugel business to private-equity firm KKR for $2.375 billion. If the hints the drugmaker has been giving lately are true, the move could be the start of two years of major asset sales. Here's what's ahead for the world's biggest pharmaceutical company.

Private-Equity Investors to Buy Del Monte for $4 Billion

Less than a week after reports that Kohlberg Kravis Roberts was in talks to buy Del Monte, the food producer says it is indeed being bought by a group of private-equity investors led by KKR. It joins a crop of other companies that have been taken private this year.

Private-Equity Firms Ask Alibaba to Join Yahoo Bid

A group of private-equity investors is calling on the CEO of Chinese Internet giant Alibaba Group to throw his support behind a buyout offer for Yahoo, Reuters reports. Alibaba founder Jack Ma is reportedly considering his options regarding the U.S. firm that holds a 40% stake in his company.

Goldman Sachs's Proprietary Traders Will Join KKR

About nine members of Goldman Sachs Group proprietary trading team are joining private-equity firm Kohlberg Kravis & Roberts after entertaining offers from investment firms such as Perella Weinberg and Blackrock.

KKR Invests in Texas Shale Assets

Private equity powerhouse Kohlberg Kravis Roberts & Co announced it will invest up to $400 million in a joint venture with Houston-based Hilcorp Energy to develop the Eagle Ford Share in South Texas.

Will KKR Take Harley-Davidson for a Ride?

Speculation that Kohlberg Kravis Roberts and Co. might buy Harley-Davidson is driving share prices up. But will Harley devotees be happy with the changes that might result if the deal goes through?